Search - tctmd.com

Displaying 21 - 40 of 267

Sort: Relevancy | Date

Presentation TCT 2025

TCT 597: Comparison of Incidence, Severity and Treatment of Silent Gastroesophageal (GE) Lesions Related to Transesophageal Echocardiography (TEE) Following Mitral vs. Tricuspid Transcatheter Edge-to-Edge Repair (M-TEER vs. T-TEER)

Presenter: Wolfgang Gerhard Bocksch

October 27, 2025

Presentation TCT 2025

Defining the Prevalence of Valvular Heart Disease in Older Americans: The PREVUE-VALVE Study

Presenter: David J. Cohen

October 27, 2025

Presentation TCT 2025

The Cutting Edge of AI in Structural and Valvular Heart Disease: What’s Next?

Presenter: Partho P. Sengupta

October 26, 2025

Presentation TCT 2025

Noise to Knowledge: Accelerating Detection of Valvular Heart Disease with Stethophone AI-Phonoscopy.

Presenter: Mark Attila Opauszky

October 26, 2025

Presentation TCT 2025

Earlier Detection of Valvular Heart Disease

Presenter: Pierre Elias

October 26, 2025

Presentation TCT 2025

TCT 857: National Trends in Nonrheumatic Valvular Heart Disease Mortality Before and After the COVID-19 Pandemic in the United States

Presenter: Hasan Munshi

October 25, 2025

Presentation NY Valves 2025

Case 4: Torrential TR in Severe HF with Shock (optimal timing for intervention)

Presenter: Mahesh V. Madhavan

June 27, 2025

Presentation NY Valves 2025

Case 3: MAC with Moderate-Severe MS/MR and Pulmonary Edema in an Elderly Patient

Presenter: Kashish Goel

June 27, 2025

Presentation NY Valves 2025

The Prognostic Value of Right Ventricular-Pulmonary Artery Coupling in Heart Valve Interventions: A Systematic Review and Meta-Analysis

Presenter: Vitaliy Androshchuk

June 27, 2025

Presentation NY Valves 2025

Case 2: Flail MV with Shock in a Non-operative Patient

Presenter: David G. Rizik

June 27, 2025

Presentation NY Valves 2025

Case 1: Severe Aortic Stenosis Presenting with Acute Shock

Presenter: Mark Bieniarz

June 27, 2025

Presentation NY Valves 2025

Trends and Outcomes After Routine Oral Anti-Coagulation in Valvular Heart Surgery in Patients Without Atrial Fibrillation

Presenter: Derrick Tam

June 27, 2025

Presentation NY Valves 2025

Treatment Algorithms for Acute Decompensated Valvular Heart Disease

Presenter: Jörg Hausleiter

June 27, 2025

Presentation NY Valves 2025

Case 4: Triple Valve Disease — Optimal Therapy Timing, Role of Surgery, and Staged Approaches

Presenter: Aakriti Gupta

June 26, 2025

Presentation NY Valves 2025

Case 3: Concomitant MR and TR — Staged, Hybrid, Robotic, and Medical Therapy Options

Presenter: Parasuram Krishnamoorthy

June 26, 2025

Presentation NY Valves 2025

Case 2: Aortic Stenosis and Mitral Stenosis — When and How to Treat?

Presenter: Lucy Michelle Safi

June 26, 2025

Presentation NY Valves 2025

Case 1: Aortic Stenosis and MR — Many Shades of Gray

Presenter: Vivian G. Ng

June 26, 2025

Presentation NY Valves 2025

Multi-Valvular Disease is Neglected and Misunderstood: Disease Patterns, Multi-modality Imaging and Treatment Strategies

Presenter: Syed Zaid

June 26, 2025

Presentation NY Valves 2025

Addressing Undertreatment And Disparities In Valvular Heart Disease: Have We Made Progress?

Presenter: Wayne Batchelor

June 25, 2025

Presentation TCT 2024

TCT 861: CURE-VHD (Comprehensive Unified Regimen for Eliminating Valvular Heart Disease): Using Artificial Intelligence to Identify Patients With Untreated Aortic Stenosis

Presenter: Daniel Mitchell

October 30, 2024

Advertisement

TCT 597: Comparison of Incidence, Severity and Treatment of Silent Gastroesophageal (GE) Lesions Related to Transesophageal Echocardiography (TEE) Following Mitral vs. Tricuspid Transcatheter Edge-to-Edge Repair (M-TEER vs. T-TEER)

Defining the Prevalence of Valvular Heart Disease in Older Americans: The PREVUE-VALVE Study

The Cutting Edge of AI in Structural and Valvular Heart Disease: What’s Next?

Noise to Knowledge: Accelerating Detection of Valvular Heart Disease with Stethophone AI-Phonoscopy.

Earlier Detection of Valvular Heart Disease

TCT 857: National Trends in Nonrheumatic Valvular Heart Disease Mortality Before and After the COVID-19 Pandemic in the United States

Case 4: Torrential TR in Severe HF with Shock (optimal timing for intervention)

Case 3: MAC with Moderate-Severe MS/MR and Pulmonary Edema in an Elderly Patient

The Prognostic Value of Right Ventricular-Pulmonary Artery Coupling in Heart Valve Interventions: A Systematic Review and Meta-Analysis

Case 2: Flail MV with Shock in a Non-operative Patient

Case 1: Severe Aortic Stenosis Presenting with Acute Shock

Trends and Outcomes After Routine Oral Anti-Coagulation in Valvular Heart Surgery in Patients Without Atrial Fibrillation

Treatment Algorithms for Acute Decompensated Valvular Heart Disease

Case 4: Triple Valve Disease — Optimal Therapy Timing, Role of Surgery, and Staged Approaches

Case 3: Concomitant MR and TR — Staged, Hybrid, Robotic, and Medical Therapy Options

Case 2: Aortic Stenosis and Mitral Stenosis — When and How to Treat?

Case 1: Aortic Stenosis and MR — Many Shades of Gray

Multi-Valvular Disease is Neglected and Misunderstood: Disease Patterns, Multi-modality Imaging and Treatment Strategies

Addressing Undertreatment And Disparities In Valvular Heart Disease: Have We Made Progress?

TCT 861: CURE-VHD (Comprehensive Unified Regimen for Eliminating Valvular Heart Disease): Using Artificial Intelligence to Identify Patients With Untreated Aortic Stenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content